Source: European Medicines Agency (EU) Publisher: SmithKline Beecham Ltd, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
AVANDIA 2 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Pink film-coated tablets debossed with “GSK” on one side and “2” on the other side. |
Each tablet contains rosiglitazone maleate corresponding to 2 mg rosiglitazone.
Excipient: Contains lactose (approximately 108 mg).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Rosiglitazone |
Rosiglitazone is a selective agonist at the PPARγ (peroxisomal proliferator activated receptor gamma) nuclear receptor and is a member of the thiazolidinedione class of anti-diabetic agents. It reduces glycaemia by reducing insulin resistance at adipose tissue, skeletal muscle and liver. |
| List of Excipients |
|---|
|
Tablet core: Sodium starch glycollate (Type A) Film coating (Opadry pink OY-L-24802): Hypromellose 6cP |
Opaque blister packs (PVC/aluminium). 56, 112, 168 or 180 film-coated tablets or 56 film-coated tablets, unit dose pack.
Not all pack sizes may be marketed.
SmithKline Beecham Ltd, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
EU/1/00/137/002-004
EU/1/00/137/013
EU/1/00/137/016
Date of first authorisation: 11 July 2000
Date of latest renewal: 11 July 2005
| Drug | Countries | |
|---|---|---|
| AVANDIA | Lithuania, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
